Background: In patients with mitral or tricuspid valve regurgitation, evaluation of regurgitant severity is essential for determining the need for surgery. While transthoracic echocardiography is widely accessible, it has limited reproducibility for grading inlet valve regurgitation. Multiplanar cardiac MRI is the quantitative standard but requires specialized local expertise, and is thus not widely available. Volumetric 4D flow MRI has potential for quantitatively grading the severity of inlet valve regurgitation in adult patients. 
patients with severe primary mitral regurgitation has been shown to improve survival rates, and is recommended even for asymptomatic patients with preserved left ventricular systolic function. [4] [5] [6] Therefore, assessment of severity of mitral regurgitation is essential for clinical management, prognosis, and timing of intervention. [5] [6] [7] Similarly, assessment of severity of tricuspid regurgitation (TR) is essential for determining the need for surgical management. 6, 8, 9 At most institutions, the distinction between "moderate" and "severe" regurgitation, currently defined by echocardiography, helps to determine nonsurgical and surgical management. Transthoracic echocardiography (TTE) is the mainstay of initial diagnosis for assessing mitral and tricuspid regurgitation, but this technique requires the complex task of conceptually integrating multiple imaging features. 10 Even in expert hands, TTE has limited interobserver agreement in distinguishing severe from nonsevere regurgitation, and it may be particularly limited when regurgitant jets are eccentric, multiple, or variable in duration. 11, 12 In contrast, quantification of mitral regurgitant volume with multiplanar cardiac magnetic resonance imaging (MRI) shows high reproducibility, 13 better predictive power of patient outcomes for chronic regurgitation, 14 and greater correlation with left ventricular remodeling after surgical repair. 15 However, multiplanar cardiac MRI is labor-intensive and requires specialized local expertise, limiting its availability. 16 MRI technologists require additional training to become familiar with cardiac anatomy and how to create cardiac imaging planes using multiple oblique localizers. Even if the technologist is able to master the creation of cardiac imaging planes, direct quantification of mitral regurgitation by 2D phase contrast (PC) is challenging, due to dynamic motion of the mitral annulus during systole, and the presence of eccentric regurgitant jets or jets that vary in position throughout systole. 16 Other indirect techniques of quantifying inlet regurgitant volume by multiplanar cardiac MRI are reliant on calculation of ventricular stroke volumes by manually contouring the endocardium in end diastole and end systole, which are prone to error especially at the basal slices. [16] [17] [18] [19] To address the limitations of TTE and multiplanar cardiac MRI, we propose the use of volumetric MRI to quantify regurgitant volume. Over the last few decades, volumetric MRI has been applied by multiple groups to measure cardiac function. [20] [21] [22] Several recent advances, including parallel-imaging, compressed-sensing, 23 combined spatial and temporal acceleration, 24, 25 and improvements in visualization and quantification software 26, 27 have made this approach feasible in a clinical environment. One element of this approach, 4D flow MRI, has been successfully applied to the evaluation of congenital heart disease (CHD), 28, 29 and can provide superior quantitative data for clinical management. 27, 30 We hypothesize that volumetric 4D flow MRI may also have potential for quantification of mitral and tricuspid regurgitant volume in adult patients. 4D flow imaging has several advantages over conventional multiplanar cardiac MRI. For example, 4D flow can be prescribed as a single volume acquisition that covers the entire heart, which does not require specialized knowledge of cardiac anatomy and imaging planes for acquisition. In addition, 4D flow may enable direct quantification of regurgitant jets with a single measurement, and could therefore reduce reliance on ventricular endocardial contouring. It is yet uncertain, however, whether 4D flow can be used to measure mitral or tricuspid regurgitation. In contrast to prior work in pediatric patients, it is possible that a freebreathing scan in adults may be more greatly affected by respiratory motion artifact due to increased tidal volumes. Furthermore, when there is "moderate" and "severe" regurgitation, there are correspondingly large pressure gradients between the ventricle and atrium that (may) yield very high-velocity jets. These high-velocity jets have greater spatial and temporal variation, which may challenge current spatial and temporal resolution limits of 4D flow MRI.
The purpose of this study was to evaluate the use of 4D flow MRI for quantification of mitral and tricuspid regurgitant volume with the hypothesis that this technique may have similar accuracy and reproducibility as the reference standard of conventional multiplanar MRI. We further evaluate intermethod (direct vs. indirect), interobserver and intraobserver reproducibility of mitral and tricuspid regurgitant volume using three quantitative metrics: 1) regurgitant flow volume (RFV), 2) regurgitant fraction (RF), and 3) regurgitant volume (RVol).
Materials and Methods
With Institutional Review Board (IRB) approval and Health Insurance Portability and Accountability Act (HIPAA) compliance, we retrospectively identified all adult patients who underwent concurrent conventional multiplanar MRI and 4D flow volumetric cardiac MRI for quantification of mitral and/or tricuspid valvular regurgitation between April 2015 and January 2017. Informed consent for this retrospective study was waived by the IRB. Twenty-one patients were identified for inclusion, with demographics as listed in Table 1 . Out of the 21 patients, 10 had MR, six had TR, and five had both MR and TR. 4D flow image data was successfully acquired in all 21 patients referred for MRI quantification. Complete 2D-PC data were obtained in 18 of the 21 patients. All MRI was performed on a 3T 750 MRI scanner with a 32-channel body array coil (GE Healthcare, Milwaukee, WI).
MRI technical parameters of spatial resolution, temporal resolution, and velocity-encoding speeds (VENC) were customized at the time of image acquisition according to patient body habitus and anticipated severity of inlet valve regurgitation based on prior echocardiographic results, if available. The parameters range within those utilized in our routine clinical practice, and are listed below.
Multiplanar MRI was performed with a combination of 2D-PC and steady-state free-precession (SSFP) imaging using multiple breath-holds and vector electrocardiographic gating, as prescribed by a board-certified radiologist with 6 years of experience in cardiovascular MRI (A.H.). SSFP short-axis imaging was performed with the following parameters reported as mean (range): temporal resolution 46 msec (42-54 msec), acquired spatial resolution 1.77 &times; 1.86 mm (1.33-2.38 3 1.61-2.08 mm), and slice thickness 8 mm. 2D-PC imaging included cross-sectional planes at the level of the aortic valve and pulmonic valve. When mitral and/or tricuspid regurgitation was visualized on SSFP images, 2D-PC imaging was then also obtained along the proximal regurgitant jet in the respective atrium as demonstrated in Fig. 1 myocardial enhancement was quantitatively evaluated by comparing signal intensity of the blood pool (measured in the ascending aorta) to the signal intensity of the basal to mid-interventricular septum in the same phase of the cardiac cycle, using an unpaired t-test.
Multiplanar MRI Analysis
Multiplanar MR images were analyzed with Circle cvi42 v. 5.3.8 (Calgary, AB, Canada). Left and right ventricular volumes were manually contoured at end systole and end diastole from base to apex on SSFP short-axis stack images in order to calculate biventricular stroke volumes (in mL), including trabeculations and papillary muscles with the blood pool in both phases of the cardiac cycle. 16 Aortic and pulmonary outputs were measured by segmenting the vessel lumen throughout the cardiac cycle. Background phase-error in 2D-PC was corrected with local soft-tissue background-correction. When 2D-PC cross-sections of the regurgitant jet were available, direct measurements of the regurgitant flow volume were performed by segmenting the flow jet during systolic phases where the jet was present.
4D Flow Volumetric MRI Analysis
4D flow analysis with background phase correction was performed on Arterys Cardio DL 2.2 (San Francisco, CA) by two readers of varied levels of expertise; one reader was a senior level radiology resident (J.F.), and the second was a cardiovascular radiologist with 6 years of cardiac imaging experience (A.H.). In a manner similar to conventional multiplanar imaging, each reader independently measured blood flow through the aortic root and main pulmonary artery in duplicate, at least 5 mm apart. Each reader also measured mitral and/or tricuspid regurgitant flow volumes by directly interrogating the regurgitant jet throughout the cardiac cycle at multiple distances from the valve plane, at least 5 mm apart, avoiding regions of velocity-aliasing and segments of severe signal dephasing (Fig. 1) . The readers were blinded to each other's results.
Calculations of Regurgitant Volume
Three metrics of quantitating regurgitant volume were included in this analysis (RFV, RF, and Rvol), recognizing that practitioners of cardiac MRI may differ in their preference to use one metric over another. RFV (in L/min) may be either measured directly by interrogating the regurgitant jet with phase-contrast (either 2D-PC or 4D flow) imaging, or indirectly by subtracting aortic forward flow from the cardiac output measured from SSFP imaging. Direct RFV was performed solely from phase-contrast flow measurements, without any measurement of cardiac stroke volume. Indirect measurements of regurgitant volume were computed as:
where SV is the stroke volume from SSFP imaging, HR is the heart rate, and Q forward is the forward output from the outlet valve. RF and RVol were normalized against cardiac output and heart rate, respectively. Calculations of regurgitant fraction (in percentage, %), for direct measurements were computed as:
Calculations of regurgitant fraction for indirect measurements were normalized against measured cardiac outputs from SSFP imaging:
Regurgitant volume (in mL/beat) was computed as the regurgitant flow volume divided by the heart rate, whether direct or indirect methods of calculating RFV were used:
RVol5RFV =HR31; 000 (4)
Statistical Analysis
Intertechnique, intermethod, interobserver, and intraobserver reliability were calculated using Pearson correlation analysis and Bland-Altman statistics in Prism (v. 7, GraphPad Software, La Jolla, CA). Reliability was also calculated with an intraclass correlation (ICC), a two-way random effects absolute agreement model 35 using custom-built script in MatLab (MathWorks, Natick, MA Intertechnique Agreement Between 4D flow and 2D-PC MRI We first compared the consistency of mitral regurgitation measurements between 4D flow and 2D-PC techniques, which demonstrated high concordance, as depicted in Fig. 3 and Table 2 . There was slightly higher intertechnique consistency (P < 0.002) in the quantification of mitral regurgitant volume using the indirect method (r 5
. This is depicted by the narrow 95% confidence interval in the linear correlation between volumetric 4D flow and multiplanar 2D-PC shown in Fig. 3 and narrower Bland-Altman (B-A) limits of agreement for the direct method (Table 2) .
We next compared the consistency of tricuspid regurgitation measurements between 4D flow and 2D-PC techniques, which also demonstrated high concordance, as depicted in Fig. 4 and Table 2 . Concordance between techniques was even higher for direct quantification of tricuspid flow volume (r 5 0.985; ICC 5 0.982), as compared to mitral regurgitant flow volume (r 5 0.813; ICC 5 0.804), and with even narrower B-A limits of agreement (Table 2) .
Intermethod Agreement Between Direct and Indirect Methods
We then compared the consistency of direct vs. indirect methods of quantifying mitral regurgitation for 4D flow and for 2D-PC, separately (Table 3 , Fig. 5, black) . Although the indirect approach is more widely used clinically, the direct method is also technically feasible, especially with 4D flow imaging. We similarly compared the consistency of direct vs. indirect methods for quantifying tricuspid regurgitation for 4D flow and for 2D-PC (Table 3 Interobserver and Intraobserver Agreement Between and Within Reader 1 and Reader 2 Finally, we assessed the interobserver and intraobserver reliability for direct quantification of inlet valve regurgitation with 4D flow, as depicted in Table 4 and Fig. 6 . Interobserver analysis demonstrated very good to excellent reproducibility between readers for quantification of mitral regurgitant flow volume (r 5 0.929 for direct, r 5 0.877 for indirect), and fraction (r 5 0.861 for direct and r 5 0.838 for indirect). Interobserver reproducibility was even higher 
Discussion
We have shown that quantification of mitral and tricuspid regurgitation by 4D flow MRI is highly reproducible and consistent across multiple methods of measurement, with high concordance to multiplanar MRI. Additionally, we find that measurement of regurgitant volume using either direct or indirect techniques yields equivalent results, whether performed with 4D flow or 2D-PC. Finally, we show that 4D flow volumetric technique has excellent interobserver and intraobserver reliability for quantification of regurgitant fraction and volume. These observations highlight the opportunity to apply 4D flow MRI to simplify and improve the robustness of quantification of valvular regurgitation. Given limited reproducibility of TTE, 4D flow MRI may provide a more reliable and accessible method for stratifying patients with severe regurgitation for subsequent mitral or tricuspid valve surgery. Our data show that although intertechnique concordance was high for direct quantification of mitral regurgitant flow volume, it was even higher for direct quantification of tricuspid regurgitant flow volume. Interobserver reproducibility was also higher for direct quantification of tricuspid regurgitation. This may be a reflection of the differing morphologies of tricuspid vs. mitral regurgitant jets. The tricuspid regurgitant jets tend to be more laminar than the mitral regurgitant jets, and much easier to perform direct measurements using either 4D flow or 2D-PC. In contrast, the mitral regurgitant jets may change orientation and position considerably during systole. This may impair the ability to perform a direct measurement with a static imaging plane with 2D-PC.
One advantage of 4D flow MRI is that this technique facilitates direct measurement of regurgitant volume, complementing the indirect measurements that are typically performed clinically by subtracting aortic forward flow from left ventricular stroke volume. This direct measurement does not require additional segmentation of ventricular volumes to determine stroke volume. While in expert hands, ventricular volumetry is highly reproducible, this may be difficult to achieve in practice outside of specialized academic centers. 17, 18 Basal segmentations in particular are subject to greater error. 18 Alternatively, since different imaging strategies may be susceptible to different sources of artifact or Journal of Magnetic Resonance Imaging measurement error, using both direct and indirect methods of measurement may provide redundancy to maximize robustness of MRI, and ensure patients are appropriately classified as having "severe" or "nonsevere" regurgitation. In practice, use of 4D flow MRI instead of conventional phase contrast provides the opportunity to perform both direct and indirect quantification of inlet valve regurgitation, without the cost of direct physician oversight of plane prescription and scan time. Current guidelines for management of mitral regurgitation are based on the presence or absence of severe regurgitation by echocardiography. 5 However, it is unclear at present what "severity" of regurgitation leads to the downstream consequences of irreversible left ventricular failure. Similarly, it is unclear whether concurrent aortic regurgitation yields similar outcomes as isolated mitral regurgitation. An earlier study by Myerson et al demonstrated poor 5-year survival outcome of patients with regurgitant volume of greater than 55 mL without mitral valve surgery. 36 They therefore suggest a mitral regurgitant volume of 55 mL or a regurgitant fraction of 40% as a threshold for surgery for asymptomatic patients. 36 However, the MRI thresholds for severe mitral regurgitation that most closely match echocardiography are uncertain, and in one study regurgitant fraction thresholds for mild, moderate, moderate to severe, and severe regurgitation were reported to be 15%, 16-25%, 26-48%, and >48%, respectively.
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In our study, one-third of our patients satisfied the 55 mL regurgitant volume threshold. With 4D flow MRI, it may now be possible to further evaluate the long-term outcomes of patients considered for surgery, at different quantitative thresholds of valvular regurgitation. With a precise quantitative technique like 4D flow, a study such as this would require fewer numbers of patients to undertake and provide prognostic information to guide surgical decisionmaking. We also observed in our study the presence of turbulent regurgitant flow jets in some patients with severe mitral regurgitation. At present, it is unclear whether turbulent flow itself has negative prognostic implications, but it is known that turbulent flow creates MRI signal voids in phase-contrast imaging, 38, 39 which negatively affect the direct quantification of blood flow. 19, 40 Future work with turbulent flow imaging may further improve the reproducibility of 4D flow measurements and prognostication. We have identified a few limitations of this study. The study was conducted at a single site with extensive experience with both multiplanar MRI and volumetric 4D flow MRI for evaluation of structural heart abnormalities. It may not be possible at all sites to perform multiplanar MRI due to lack or unavailability of local specialized expertise. In addition, while 4D flow MRI has recently become a clinical product by one MRI vendor, it is not yet widely available on all MRI platforms, and it is unclear if other platforms or analysis software can obtain measurements of similar accuracy or reproducibility. However, the present work may provide a template for future work on other platforms and analysis software.
Additionally, this study was designed to specifically focus on comparison between MRI techniques, without comparison with echocardiography. Prior studies have explored the reliability and accuracy of valve regurgitation quantitation between echocardiography and multiplanar cardiac MRI, which have shown multiplanar cardiac MRI to have high reproducibility, 13 better predictive power of patient outcomes for chronic regurgitation, 14 and greater correlation with left ventricular remodeling after surgical repair. 15 To our knowledge, there are no similar studies directly comparing echocardiography with 4D flow MRI. The present work, in combination with these prior studies, may serve as a basis for such future evaluation.
In conclusion, this study offers technical evidence supporting the application of 4D flow cardiac MRI to quantify mitral and tricuspid regurgitant volume. 4D flow may simplify evaluation of structural cardiac abnormalities with MRI by reducing the workload and expertise required of the technologist performing the MRI, eliminating the need for on-site physician expertise, and reducing the need for postprocessing of ventricular stroke volumes in order to quantify inlet valve regurgitation. If used in combination with existing indirect measurements, it can provide even greater redundancy and robustness to quantification of regurgitant volume to help guide clinical management of these patients.
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